E. Waxman

发表

N-methyl-D-aspartate Receptor Subtypes: Multiple Roles in Excitotoxicity and Neurological Disease

E. Waxman, D. Lynch, 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

Environments of the four tryptophans in the extracellular domain of human tissue factor: comparison of results from absorption and fluorescence difference spectra of tryptophan replacement mutants with the crystal structure of the wild-type protein.

C. A. Hasselbacher, I. Polikarpov, A. Guha, 1995, Biophysical journal.

Leucine-Rich Repeat Kinase 2 Expression Leads to Aggresome Formation That Is Not Associated With &agr;-Synuclein Inclusions

X. Li, T. Dawson, E. Waxman, 2009, Journal of neuropathology and experimental neurology.

Determination of the tryptophan:tyrosine ratio in proteins.

C. A. Hasselbacher, E. Waxman, E. Rusinova, 1993, Analytical biochemistry.

Characterization of kinases involved in the phosphorylation of aggregated α‐synuclein

E. Waxman, B. Giasson, 2011, Journal of neuroscience research.

Residue Glu83 Plays a Major Role in Negatively Regulating α Synuclein Amyloid Formation

E. Waxman, B. Giasson, Kristel L. Emmer, 2010 .

Spectral enhancement of proteins: biological incorporation and fluorescence characterization of 5-hydroxytryptophan in bacteriophage lambda cI repressor.

C. A. Hasselbacher, D. F. Senear, E. Waxman, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex.

A. Guha, W. Konigsberg, Y. Nemerson, 1992, Biochemistry.

Human factor VIIa and its complex with soluble tissue factor: evaluation of asymmetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods.

Y. Nemerson, T. Laue, E. Waxman, 1993, Biochemistry.

N-Methyl-D-aspartate Receptor Subtype Mediated Bidirectional Control of p38 Mitogen-activated Protein Kinase*

E. Waxman, D. Lynch, 2005, Journal of Biological Chemistry.

The primary self-assembly reaction of bacteriophage lambda cI repressor dimers is to octamer.

D. F. Senear, T. Laue, E. Waxman, 1993, Biochemistry.

E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment*

E. Waxman, B. Giasson, Jason P. Covy, 2011, The Journal of Biological Chemistry.

Specificity and Regulation of Casein Kinase-Mediated Phosphorylation of &agr;-Synuclein

E. Waxman, B. Giasson, 2008, Journal of neuropathology and experimental neurology.

Clinical and pathological characteristics of patients with Leucine‐rich repeat kinase‐2 mutations

E. Waxman, B. Giasson, V. V. Van Deerlin, 2009, Movement disorders : official journal of the Movement Disorder Society.

Refining Hydrodynamic Shapes of Proteins: The Combination of Data From Analytical Ultracentrifugation and Time-Resolved Fluorescence Anisotropy Decay

T. Laue, E. Waxman, W. Laws, 1994 .

N-Methyl-d-aspartate Receptor-dependent Regulation of the Glutamate Transporter Excitatory Amino Acid Carrier 1*

I. Baconguis, E. Waxman, D. Lynch, 2007, Journal of Biological Chemistry.

Induction of Intracellular Tau Aggregation Is Promoted by α-Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of Tau

E. Waxman, B. Giasson, 2011, The Journal of Neuroscience.

Molecular mechanisms of alpha-synuclein neurodegeneration.

E. Waxman, B. Giasson, Benoit I Giasson, 2009, Biochimica et biophysica acta.

Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization.

E. Waxman, B. Giasson, Joseph R. Mazzulli, 2009, Biochemistry.

Characterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants

E. Waxman, B. Giasson, Jason P. Covy, 2012, Journal of neuroscience research.

Interactions of Postsynaptic Density-95 and the NMDA Receptor 2 Subunit Control Calpain-Mediated Cleavage of the NMDA Receptor

E. Waxman, D. Lynch, Y. Dong, 2004, The Journal of Neuroscience.

Characterization of antibodies that selectively detect α-synuclein in pathological inclusions

E. Waxman, B. Giasson, J. Duda, 2008, Acta Neuropathologica.

A novel, high‐efficiency cellular model of fibrillar α‐synuclein inclusions and the examination of mutations that inhibit amyloid formation

E. Waxman, B. Giasson, 2010, Journal of neurochemistry.

Molecular and cellular approaches to the treatment of neurological disease

E. Waxman, Waxman E, 1994 .

Rat Dentate Gyrus Mediated Facilitation of High-Frequency Input in the - Kindling Induces Transient NMDA Receptor

I. Módy, G. Westbrook, U. Heinemann, 2015 .

Residue Glu83 plays a major role in negatively regulating alpha-synuclein amyloid formation.

E. Waxman, B. Giasson, Kristel L. Emmer, 2010, Biochemical and biophysical research communications.

Gain and loss of function variants in EZH1 disrupt neurogenesis and cause dominant and recessive neurodevelopmental disorders

H. Hakonarson, D. Reinberg, G. Ming, 2023, Nature communications.

Generation of a human Tropomyosin 1 knockout iPSC line.

J. A. Maguire, P. Gadue, E. Waxman, 2023, Stem cell research.

Generation of a human Tropomyosin 1 knockout iPSC line

J. A. Maguire, P. Gadue, E. Waxman, 2023, bioRxiv.

Cross-site reproducibility of human cortical organoids reveals consistent cell type composition and architecture

Alvaro A. Beltran, Tala M. Farah, Jason L. Stein, 2023, bioRxiv.

Bach2 is a potent repressor of Nrf2-mediated antioxidant enzyme expression in dopaminergic neurons

E. Waxman, 2019, bioRxiv.

Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switching

J. A. Maguire, E. Waxman, E. Heller, 2023, Nature communications.

Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency

J. A. Maguire, A. Ballabio, T. Dierks, 2023, EMBO molecular medicine.